Concepedia
Statistics
Publications
22
Citations
1.5K
H-Index
16
Active since
1994
Affiliations
Pfizer (United States)(Current)
Oklahoma Medical Research Foundation
University of Oklahoma Health Sciences Center
Inserm
Takeda (United States)
Jacques Ermolieff is an author at Pfizer (United States) specializing in medicine, drug discovery, and pharmacology.
Top concepts
MedicinePharmacologyDrug DiscoveryBiochemistryNatural SciencesMolecular PharmacologyMedicinal ChemistrySignal TransductionCell SignalingDrug Development
Publications per year
1994–2020
Polyoxometalate HIV-1 Protease Inhibitors. A New Mode of Protease Inhibition
Deborah A. Judd, James H. Nettles, Neysa Nevins et al. · Journal of the American Chemical Society · 2001 · 366 citations
Structure-Based Design: Potent Inhibitors of Human Brain Memapsin 2 (β-Secretase)
Arun K. Ghosh, Geoffrey Bilcer, Cynthia Harwood et al. · Journal of Medicinal Chemistry · 2001 · 224 citations · Full text
Design of Potent Inhibitors for Human Brain Memapsin 2 (β-Secretase)
Arun K. Ghosh, Dong-Woo Shin, Debbie Downs et al. · Journal of the American Chemical Society · 2000 · 208 citations · Full text
Drug Target, Altmetric Attention Score, Social Sciences +16
Proteolytic Activation of Recombinant Pro-memapsin 2 (Pro-β-secretase) Studied with New Fluorogenic Substrates
Jacques Ermolieff, Jeffrey A. Loy, Gerald Koelsch et al. · Biochemistry · 2000 · 126 citations
Protein Secretion, Proteolytic Activation, Cytoskeleton +19
A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
Iwona Bujalska, Laura Gathercole, Jeremy Tomlinson et al. · Journal of Endocrinology · 2008 · 84 citations · Full text
1–5 of 22